Trispecific And/or Trivalent Binding Proteins For Prevention Or Treatment Of HIV Infection
Patent Cooperation Treaty
PCT/US2016/058540
Filed on 2016-10-24
PCT/US2016/058540
Filed on 2016-10-24
Trispecific And/or Trivalent Binding Proteins For Prevention Or Treatment Of HIV Infection
European Patent
16305211.1
Filed on 2016-02-24
16305211.1
Filed on 2016-02-24
Dengue Tetravalent Vaccine Containing a Common 30 Nucleotide Deletion in The 3'-UTR of Dengue Types 1,2,3, And 4, or Antigenic Chimeric Dengue Viruses 1,2,3, And 4
European Patent
17155603.8
Filed on 2003-04-25
17155603.8
Filed on 2003-04-25
Polyvalent Influenza Virus-Like Particles (VLPS) And Use As Vaccines
US Patent 10,130,700
Filed on 2016-12-09
Filed on 2016-12-09
Polyvalent Influenza Virus-Like Particles (VLPS) And Use as Vaccines
India
201617043281
Filed on 2015-05-08
201617043281
Filed on 2015-05-08
Polyvalent Influenza Virus-Like Particles (VLPS) And Use as Vaccines
European Patent
15724151.4
Filed on 2015-05-08
15724151.4
Filed on 2015-05-08
Polyvalent Influenza Virus-Like Particles (VLPS) And Use as Vaccines
China
201580037799.4
Filed on 2015-05-08
201580037799.4
Filed on 2015-05-08
A Novel Method Of Vaccination With An Attenuated RSV Vaccine Formulation
Patent Cooperation Treaty
PCT/US2016/060672
Filed on 2016-11-04
PCT/US2016/060672
Filed on 2016-11-04
Adenovirus Serotype 26 and Serotype 35 Filovirus Vaccines
Japan
2016-206679
Filed on 2016-10-27
2016-206679
Filed on 2016-10-27